Antibody-mediated rejection in hand transplantation

Transplant International

Volumn 27, Issue 2, 2014, Pages

  Weissenbacher, Annemarie ^a   Hautz, Theresa ^a   Zelger, Bernhard ^a   Zelger, Bettina G ^b   Mayr, Verena ^c   Brandacher, Gerald ^d   Pratschke, Johann ^a   Schneeberger, Stefan ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^c Central Institute for Blood Transfusion and Immunology   (Austria)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibodies; outcome; rejection treatment; rituximab; vascularized composite allotransplantation

Indexed keywords

ADDRESSIN; ANTIBODY; B CELL ACTIVATING FACTOR; CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; COMPLEMENT COMPONENT C4D; DONOR SPECIFIC ANTIBODY; EVEROLIMUS; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PERIPHERAL NODE ADDRESSIN; RITUXIMAB; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ANTIBODY MEDIATED REJECTION; ARM EDEMA; ARM PAIN; ARTICLE; B LYMPHOCYTE; CASE REPORT; CD4 CD8 RATIO; CELL AGGREGATION; DERMIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FLUORESCENCE ACTIVATED CELL SORTING; FOREARM; GRAFT REJECTION; HAND EDEMA; HAND TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTOSIS; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN BIOPSY; STEROID THERAPY; VENULE;

ANTIBODIES; OUTCOME; REJECTION TREATMENT; RITUXIMAB; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION;

ADULT; ANTIBODIES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; B-LYMPHOCYTES; EDEMA; GRAFT REJECTION; GRAFT SURVIVAL; HAND TRANSPLANTATION; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOCYTES; MALE; SKIN; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84892368973     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12233     Document Type: Article

References (20)

1. Jeannet M, Pinn VW, Flax MH, Winn HJ, Russell PS,. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1979; 181: 111.
2. Nankivell BJ, Alexander SI,. Rejection of the kidney allograft. N Engl J Med 2010; 363: 1451.
3. Van Saase J, van der Woude FJ, Thorogood J, et al,. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995; 59: 1280.
4. Cendales LC, Kanitakis J, Schneeberger S, et al,. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008; 8: 1396.
5. Hautz T, Zelger B, Brandacher G, et al,. Histopathologic characterization of mild rejection (grade I) in skin biopsies of human hand allografts. Transpl Int 2012; 25: 56.
6. Kanitakis J, McGregor B, Badet L, et al,. Absence of C4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation 2007; 84: 265.
7. Hautz T, Zelger B, Grahammer J, et al,. Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am J Transplant 2010; 10: 1200.
8. Schneeberger S, Gorantla VS, Brandacher G, et al,. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg 2013; 257: 345.
9. Schneeberger S, Ninkovic M, Gabl M, et al,. First forearm transplantation: outcome at 3 years. Am J Transplant 2007; 7: 1753.
10. Thibault-Espitia A, Foucher Y, Danger R, et al,. BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies. Am J Transplant 2012; 12: 2754.
11. Unadkat JV, Schneeberger S, Goldbach C, et al,. Investigation of antibody-mediated rejection in composite tissue allotransplantation in a rat limb transplant model. Transplant Proc 2009; 41: 542.
12. Hidalgo LG, Campbell PM, Sis B, et al,. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532.
13. Landin L, Cavadas PC, Nthumba P, Ibanez J, Vera-Sempere F,. Preliminary results of bilateral arm transplantation. Transplantation 2009; 88: 749.
14. Gong Q, Ou Q, Ye S, et al,. Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy. J Immunol 205; 174: 817.
15. Vo AA, Lukovsky M, Toyoda M, et al,. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008; 359: 242.
16. Faguer S, Kamar N, Guilebeaud-Frugier C, et al,. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 2007; 83: 1277.
17. Drayton DL, Liao S, Mounzer RH, Ruddle NH,. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006; 7: 344.
18. Baddoura FK, Nasr IW, Wrobel B, Li Q, Ruddle NH, Lakkis FG,. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant 2005; 5: 510.
19. Thaunat O, Graff-Dubois S, Brouard S, et al,. Immune responses elicited in tertiary lymphoid tissues display distinctive features. PLoS ONE 2010; 5: e11398.
20. Thaunat O,. Pathophysiologic significance of B-cell clusters in chronically rejected grafts. Transplantation 2011; 92: 121.